Title: Randomised Clinical Trial of Weekly vs. Triweekly Cisplatin Based Chemotherapy Concurrent with Radiotherapy in the Treatment of Locally Advanced Cervical Cancer
Authors: Dr Niharika Panda, Dr Subrata Bag, Dr Sagarika Samantaray, Dr Lucy Pattanayak, Dr Umakant Satapathy
DOI: https://dx.doi.org/10.18535/jmscr/v5i4.54
Abstract
Cervical cancer is the most common malignancy in women. The standard treatment for locally advanced surgically inoperable case is cisplatin based chemo-radiation as cisplatin is a better radio-sensitizer in comparison to 5FU. Weekly cisplatin 40mg/m2 chemotherapy is currently considered the standard regimen in locally advanced cervical cancer. Two Arms of patients (41 in each) suffering from carcinoma cervix were studied for their compliance & toxicity to the regimens of weekly cisplatin 40mg/m2 with concurrent radiation and tri-weekly cisplatin 75mg/m2 with concurrent radiation. The toxicities like haematological, gastrointestinal and dermatological and the response were compared. It is observed that the three weekly cisplatin 75mg/m2 chemotherapy concurrent with radiotherapy may be more effective and feasible and has comparable outcome with weekly cisplatin 40mg/m2 chemotherapy which is currently considered the standard regimen in locally advanced cervical cancer. The response may be due to higher peak concentration of cisplatin enhancing the synergy of chemo-radiation.
Keywords-cancer cervix, weekly vs tri-weekly cisplatin with concurrent radiation.
